Altium Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Altium Wealth Management's BMY Position: Q2 2022 in Review
Altium Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 29% in Q2 2022, buying an estimated $392K and bringing the position to 23,155 shares worth $1.78M. The position accounts for 0.13% of the portfolio, ranked #97.
Altium Wealth Management first reported a position in BMY in Q4 2017 and has held it in 19 quarters since. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.
- Altium Wealth Management held 23,155 shares of Bristol-Myers Squibb worth $1.78M as of Q2 2022.
- Altium Wealth Management bought 5,153 Bristol-Myers Squibb shares in Q2 2022, an estimated $392K.
- Bristol-Myers Squibb made up 0.13% of Altium Wealth Management's portfolio in Q2 2022, its #97 holding.
- Altium Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 19 quarters since.
- 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.
Based on Altium Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.